相似文献
1
Humoral immune system in inflammatory bowel disease: I. Complement levels.
Gut. 1977 Sep;18(9):749-53. doi: 10.1136/gut.18.9.749.
2
Complement alterations in inflammatory bowel disease.
Gastroenterology. 1979 Jun;76(6):1374-9.
3
Humoral immune system activity in inflammatory bowel disease.
Scand J Gastroenterol. 1975;10(5):545-9.
4
Significance of serum complement levels in patients with gastrointestinal disease.
J Clin Pathol. 1979 Aug;32(8):798-801. doi: 10.1136/jcp.32.8.798.
5
Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
Digestion. 1975;13(1-2):100-3. doi: 10.1159/000197698.
6
Serum complement components in Henoch-Schönlein purpura.
Arch Dis Child. 1978 May;53(5):417-9. doi: 10.1136/adc.53.5.417.
7
The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
Gastroenterology. 1976 Feb;70(2):181-5.
8
Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
Gut. 1980 Dec;21(12):1030-4. doi: 10.1136/gut.21.12.1030.
9
Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis.
Nephron. 1981;27(1):9-14. doi: 10.1159/000182012.
10
Systemic complement fixation after fractures.
Lancet. 1978 Feb 18;1(8060):395-6. doi: 10.1016/s0140-6736(78)91125-x.
引用本文的文献
1
Properdin, transcortin and HGFAC are novel plasma biomarkers in canine chronic inflammatory enteropathies from active disease to remission.
Sci Rep. 2025 Jul 15;15(1):25443. doi: 10.1038/s41598-025-11474-0.
2
Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?
Front Cell Infect Microbiol. 2020 Aug 14;10:418. doi: 10.3389/fcimb.2020.00418. eCollection 2020.
3
Intestinal proteomic analysis of a novel non-human primate model of experimental colitis reveals signatures of mitochondrial and metabolic dysfunction.
Mucosal Immunol. 2019 Nov;12(6):1327-1335. doi: 10.1038/s41385-019-0200-2. Epub 2019 Sep 3.
4
Comorbidity of inflammatory bowel disease with atypical hemolytic uremic syndrome in pediatric patients.
Clin Nephrol Case Stud. 2019 Jun 25;7:35-40. doi: 10.5414/CNCS109511. eCollection 2019.
5
A cross-ethnic survey of CFB and SLC44A4, Indian ulcerative colitis GWAS hits, underscores their potential role in disease susceptibility.
Eur J Hum Genet. 2016 Jan;25(1):111-122. doi: 10.1038/ejhg.2016.131. Epub 2016 Oct 19.
6
High normal serum levels of C3 and C1 inhibitor, two acute-phase proteins belonging to the complement system, occur more frequently in patients with Crohn's disease than ulcerative colitis.
Dig Dis Sci. 2003 Jun;48(6):1186-92. doi: 10.1023/a:1023793502456.
7
Hyperthyroidism and ulcerative colitis: report of two cases and a review of the literature.
J Natl Med Assoc. 1980 Feb;72(2):127-31.
8
In vitro studies on cellular and humoral chemotaxis in Crohn's disease using the under agarose gel technique.
Gut. 1981 Jul;22(7):566-70. doi: 10.1136/gut.22.7.566.
9
Circulating immune complexes in Crohn's disease. Their characterization and interrelationship with components of the complement system.
Dig Dis Sci. 1982 Feb;27(2):129-38. doi: 10.1007/BF01311706.
10
Assessment of drug therapy in inflammatory bowel disease.
Br J Clin Pharmacol. 1982 Aug;14(2):159-70. doi: 10.1111/j.1365-2125.1982.tb01957.x.
本文引用的文献
1
Cortisone in ulcerative colitis; final report on a therapeutic trial.
Br Med J. 1955 Oct 29;2(4947):1041-8. doi: 10.1136/bmj.2.4947.1041.
2
Positive epinephrine skin test for "circulating endotoxin" in inflammatory disease of the intestine.
Am J Clin Pathol. 1965 Dec;44(6):642-7. doi: 10.1093/ajcp/44.6.642.
3
Decreased properdin activity in acute glomerulonephritis.
Int Arch Allergy Appl Immunol. 1969;36(6):592-8. doi: 10.1159/000230780.
4
Serial complement component alterations in acute glomerulonephritis and systemic lupus erythematosus.
Clin Exp Immunol. 1969 Feb;4(2):191-202.
5
Short-term course and prognosis of Crohn's disease.
Gut. 1974 Jun;15(6):435-43. doi: 10.1136/gut.15.6.435.
6
Serum complement in chronic liver disease.
Gut. 1973 Jun;14(6):451-6. doi: 10.1136/gut.14.6.451.
7
Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.
Gut. 1974 Oct;15(10):835.
8
High levels of serum complement factors in juvenille rheumatoid arthritis.
Ann Rheum Dis. 1974 May;33(3):243-7. doi: 10.1136/ard.33.3.243.
9
Circulating immune complexes in inflammatory bowel disease.
Clin Exp Immunol. 1973 Jun;14(2):219-26.
10
Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.
J Exp Med. 1968 Nov 1;128(5):1049-57. doi: 10.1084/jem.128.5.1049.
Zotero 插件